Evidence map›Paper›PMID 27150009›Full record

ArticleLeukemia2016

Mesenchymal stromal cell-derived extracellular vesicles rescue radiation damage to murine marrow hematopoietic cells.

S Wen, M Dooner, Y Cheng, E Papa, M Del Tatto, M Pereira, Y Deng, L Goldberg, J Aliotta, D Chatterjee and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in Leukemia, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 133 papers.

0numbers the graph read from it
0cells of the map it votes in
133citing papers in PubMed
12.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

133 citing papers in PubMed, 225 citations in OpenAlex.

  1. Article
  2. Radiomitigators: Breakthroughs in Post-Radiation Recovery.Antioxidants (Basel, Switzerland) · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Cell Therapies for Acute Radiation Syndrome.International journal of molecular sciences · 2024
    Review

73 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 2 countries.

S WenDivision of Hematology/Oncology, Brown University, Rhode Island Hospital, Providence, RI, USA.
M DoonerDivision of Hematology/Oncology, Brown University, Rhode Island Hospital, Providence, RI, USA.
Y ChengDivision of Hematology/Oncology, Brown University, Rhode Island Hospital, Providence, RI, USA.
E PapaDivision of Hematology/Oncology, Brown University, Rhode Island Hospital, Providence, RI, USA.
M Del TattoDivision of Hematology/Oncology, Brown University, Rhode Island Hospital, Providence, RI, USA.
M PereiraDivision of Hematology/Oncology, Brown University, Rhode Island Hospital, Providence, RI, USA.
Y DengDivision of Hematology/Oncology, Brown University, Rhode Island Hospital, Providence, RI, USA.
L GoldbergDivision of Hematology/Oncology, Brown University, Rhode Island Hospital, Providence, RI, USA.
J AliottaDivision of Hematology/Oncology, Brown University, Rhode Island Hospital, Providence, RI, USA.
D ChatterjeeDivision of Hematology/Oncology, Brown University, Rhode Island Hospital, Providence, RI, USA.
C StewartDivision of Hematology/Oncology, Brown University, Rhode Island Hospital, Providence, RI, USA.
A CarpanettoDepartment of Medical Sciences, University of Torino, Torino, Italy.
F CollinoDepartment of Medical Sciences, University of Torino, Torino, Italy.
S BrunoDepartment of Medical Sciences, University of Torino, Torino, Italy.
G CamussiDepartment of Medical Sciences, University of Torino, Torino, Italy.
P QuesenberryDivision of Hematology/Oncology, Brown University, Rhode Island Hospital, Providence, RI, USA.
Rhode Island Hospital · USBrown University · USUniversity of Turin · IT

Funding

TYORISINE PHOSPHATASE SHP2 IN HEMATOPOIETIC STEM CELL PROPERTY MAINTENANCEP20RR025179 · NCRR · RHODE ISLAND HOSPITAL · PI QUESENBERRY, PETER J. · 2009 to 2011
$6.4M
Stem Cell Biology: New Directions in Clinical and Basic ResearchP20GM103468 · NIGMS · RHODE ISLAND HOSPITAL · PI QUESENBERRY, PETER J. · 2012 to 2013
$4.5M
Genetic information transfer to hematopoietic cells: Role of microvesiclesR01HL103726 · NHLBI · RHODE ISLAND HOSPITAL · PI QUESENBERRY, PETER J. · 2011 to 2014
$1.5M
Regulation of renal and bone marrow injury by extracellular vesicle non-coding RNUH3TR000880 · NCATS · RHODE ISLAND HOSPITAL · PI QUESENBERRY, PETER J. · 2015 to 2017
$1.1M
Hematology Post Doctoral TrainingT32HL116249 · NHLBI · RHODE ISLAND HOSPITAL · PI QUESENBERRY, PETER J. · 2013 to 2017
$985k
Re-evalulating the hematopoetic stem cell pool to enhance the transplantable populationK08HL118117 · NHLBI · RHODE ISLAND HOSPITAL · PI GOLDBERG, LAURA RACHEL · 2015 to 2019
$791k
Regulation of renal and bone marrow injury by extracellular vesicle non-coding RNUH2TR000880 · NCATS · RHODE ISLAND HOSPITAL · PI QUESENBERRY, PETER J. · 2013 to 2014
$498k
NCATS NIH HHS UH2 TR000880NCATS NIH HHS UH3 TR000880NCRR NIH HHS P20 RR025179NHLBI NIH HHS K08 HL118117NHLBI NIH HHS R01 HL103726NHLBI NIH HHS T32 HL116249NIGMS NIH HHS P20 GM103468
6 · The paper itself

Abstract

Mesenchymal stromal cells (MSCs) have been shown to reverse radiation damage to marrow stem cells. We have evaluated the capacity of MSC-derived extracellular vesicles (MSC-EVs) to mitigate radiation injury to marrow stem cells at 4 h to 7 days after irradiation. Significant restoration of marrow stem cell engraftment at 4, 24 and 168 h post irradiation by exposure to MSC-EVs was observed at 3 weeks to 9 months after transplant and further confirmed by secondary engraftment. Intravenous injection of MSC-EVs to 500cGy exposed mice led to partial recovery of peripheral blood counts and restoration of the engraftment of marrow. The murine hematopoietic cell line, FDC-P1 exposed to 500cGy, showed reversal of growth inhibition, DNA damage and apoptosis on exposure to murine or human MSC-EVs. Both murine and human MSC-EVs reverse radiation damage to murine marrow cells and stimulate normal murine marrow stem cell/progenitors to proliferate. A preparation with both exosomes and microvesicles was found to be superior to either microvesicles or exosomes alone. Biologic activity was seen in freshly isolated vesicles and in vesicles stored for up to 6 months in 10% dimethyl sulfoxide at -80 °C. These studies indicate that MSC-EVs can reverse radiation damage to bone marrow stem cells.

Indexed as

AnimalsBone Marrow CellsDNA DamageExtracellular VesiclesGraft SurvivalHematopoietic Stem CellsHumansMaleMesenchymal Stem CellsMiceRadiation EffectsStem Cell TransplantationTransplantation, HeterologousTreatment Outcome

Identifiers

PMID27150009
PMCPMC5093052
OpenAlexW2346103630

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.